SRC1在胃癌中的表达及其与预后的关系

doi:10.11904/j.issn.1002-3070.2018.02.001

摘要/Abstract

摘要： 目的探讨类固醇受体辅助活化因子-1(Steroid receptor coactivator 1,SRC1)蛋白在胃癌组织中的表达及其与患者临床病理参数和预后的相关性。方法收集36例胃癌组织及其配对的癌旁组织,qRT-PCR法及Western blot法检测SRC1mRNA和蛋白的表达水平。应用免疫组化方法检测286例胃癌组织中SRC1蛋白的表达情况,分析SRC1蛋白表达与胃癌临床病理参数的关系及其对患者预后的影响。结果与癌旁组织相比,胃癌组织中SRC1mRNA表达水平明显降低(P=0.004),SRC1蛋白表达水平也明显降低。SRC1蛋白的表达强度与胃癌患者临床病理参数无显著关系。Kaplan-Meier生存曲线分析发现高表达SRC1组5年生存率显著高于低表达组(P=0.009)。Cox回归分析结果显示低表达SRC1(P=0.002)、肿瘤侵袭T_4a~T_4b(P=0.004)、淋巴结转移N(P=0.038)、远处转移M1(P＜0.001)是独立影响总生存时间的预后不良因素。SRC1低表达较高表达患者预后差。结论胃癌中SRC1的表达明显降低,胃癌组织中的SRC1表达水平可作为独立的胃癌预后不良因素,其过低表达与胃癌的发展密切相关,可能作为一个抑癌基因及判断胃癌患者预后的标志物。

关键词: SRC1, 胃癌, 预后

Abstract: Objective The Objective of this study was to investigate the expression of SRC1 protein in gastric cancer,and its correlation with clinicopathological parameters and prognosis.Methods Thirty-six gastric cancer tissues and matched paracancerous tissues were collected.The expressions of SRC1 at levels of mRNA and protein were detected by qRT-PCR and Western blot.The expression of SRC1 protein in 286 cases of gastric cancer was detected by immunohistochemistry.The relationship between the expression of SRC1 protein and the clinicopathologic parameters of gastric cancer and the prognosis of the patients were analyzed.Results The expression of SRC1 at levels of mRNA and protein were significantly lower in gastric cancer tissues than that in the normal gastric tissues(P=0.004).There was no significant correlation between the expression of SRC1 protein in gastric cancer tissues and the clinicopathological parameters of gastric cancer patients.Kaplan-Meier survival curve analysis showed that the 5-year survival rate of SRC1 overexpressing group was significantly higher than that in the low expression group(P=0.009).Cox regression analysis showed that the low expression of SRC1,tumor invasion of T_4a~T_4b,lymph node metastasis N,and distant metastasis M1 were independent prognosis predictors of total survival time(P＜0.05 or P＜0.001).The low expression of SRC1 protein was associated with poor prognosis in gastric cancer.Conclusion The expression of SRC1 protein is low in gastric cancer.The SRC1 expression may be an independent prognostic factor for gastric cancer.The overexpression of SRC1 may be related to the development of gastric cancer,which may serve as a marker of tumor suppressor gene and prognosis of gastric cancer patients.

Key words: SRC1, Gastric cancer, Prognosis

中图分类号:

R735.2

姚强, 王宽, 薛英威. SRC1在胃癌中的表达及其与预后的关系[J]. 实用肿瘤学杂志, 2018, 32(2): 97-102.

YAO Qiang, WANG Kuan, XUE Yingwei. Expression of SRC1 in gastric cancer and its prognosis[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 97-102.

参考文献

1 季加孚.我国胃癌防治研究三十年回顾[J].中国肿瘤临床,2013,40(22):1345-1351.
2 IARC.All cancers(excluding non-melanoma skin cancer)estimated incidence,mortality and prevalence worldwide in 2012.http://globocan.iarc.Fr/Pages/fact_sheets_cancer.aspx.
3 Herrero R,Park JY,Forman D.The fight against gastric cancer-the IARC Working Group report[J].Best Pract Res Clin Gastroenterol,2014,28(6):1107-1114.
4 中华人民共和国国家卫生和计划生育委员会.http://www.moh.gov.cn/zwgkzt/tjnj/list.
5 Onate SA,Tsai SY,Tsai MJ,et al.Sequence and characterization of a coactivator for the steroid hormone receptor superfamily[J].Science,1995,270(5240):1354-1357.
6 Na SY,Lee SK,Han SJ,et al.Steroid receptor coactivator1 interacts with the p50 subunit and coactivates nuclear factor kappa B-mediated transactivations[J].J Biol Chem,1998,273(18):10831-10834.
7 Lee SK,Kim HJ,Na SY,et al.Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fossubunits[J].J Biol Chem,1998,273(27):16651-16654.
8 Hong H,Kohli K,Trivedi A,et al.GRIP1,a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors[J].Proc Natl Acad Sci U S A,1996,93(10):4948-4952.
9 Xu J,O′Malley BW.Molecular mechanisms and cellular biology of the steroid receptor coactivator(SRC)family in steroid receptor function[J].Rev Endocr Metab Disord,2002,3(3):185-192.
10 Carapeti M,Aguiar RC,Chase A,et al.Assignment of the steroid receptor coactivator1(SRC1)gene to human chromosome band 2p23[J].Genomics,1998,52(2):242-244.
11 Wang Y,Lonard DM,Yu Y,et al.Small molecule inhibition of the steroid receptor coactivators,SRC-3 and SRC-1[J].Mol Endocrinol,2011,25(12):2041-2053.
12 Zhang D,Guo Q,Bian C,et al.Alterations of steroid receptor coactivator-1(SRC-1)immunoreactivities in specific brain regions of young and middle-aged female Sprague-Dawley rats[J].Brain Res,2011,1382:88-97.
13 Mori R,Wang Q,Quek ML,et al.Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer[J].Anticancer Res,2008,28:425-430.
14 Agoulnik IU,Vaid A,Bingman WE,et al.Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression[J].Cancer Res,2005,65(17):7959-7967.
15 Tien JC,Zhou S,Xu J.The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression[J].Int J Biol Sci,2009,5(3):256-264.
16 De Blacam C,Byrne C,Hughes E.HOXC11-SRC-1 regulation of S100β in cutaneous melanoma:new targets for the kinase inhibitor dasatinib[J].Br J Cancer,2011,105(1):118-123.

[1]	王晓雅,肖斌,廖扬,唐荣芝,孙朝晖,李林海. CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析[J]. 实用肿瘤学杂志, 2019, 33(3): 206-210.
[2]	秦文,赵楠楠,韩永焕,徐亚君. ZNF436在胃癌中的表达及调控WNT/β-catenin对胃癌细胞迁移及侵袭的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 222-227.
[3]	孟海,杜观祥,朱利玲,汤琪云. WEE1在胃癌组织中的表达及对患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 239-243.
[4]	刘佳音,燕飞虎,张艳桥. 凋亡基因Caspase3和Caspase7单核苷酸多态性与胃癌遗传易感性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 250-255.
[5]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[6]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[7]	石小康, 丁佑铭, 汪斌, 余斌, 徐雨. UBE2T在原发性肝癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(2): 128-133.
[8]	卢姣云, 张清媛. 实验室标志物在弥漫大B细胞淋巴瘤预后中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 183-187.
[9]	白玉贤, 马仲娟, 苏颖玲, 慕安国, 谢蕊. 胃癌患者FHIT、hMLH1、p16、RAR-beta、Reprimo和TIMP3基因的甲基化研究[J]. 实用肿瘤学杂志, 2019, 33(1): 8-13.
[10]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[11]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[12]	马健力, 张明辉, 姬宏飞, 徐向英. PD-L1蛋白与CD8⁺TILs联合检测在可切除肺腺癌预后评估中的临床意义[J]. 实用肿瘤学杂志, 2019, 33(1): 40-46.
[13]	杨洪波, 石洁, 叶勇, 李文成, 邓兆平. COL5A2在膀胱癌组织中的表达及其与临床病理特征和预后的相关性分析[J]. 实用肿瘤学杂志, 2019, 33(1): 52-56.
[14]	张宝综述, 郑志超校审. 进展期胃癌淋巴结清扫研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 78-81.
[15]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.